Invention Grant
- Patent Title: Pharmaceutical compounds
-
Application No.: US16319961Application Date: 2017-07-26
-
Publication No.: US11053213B2Publication Date: 2021-07-06
- Inventor: Peter Hewitt , Mary Melissa McFarland , James Samuel Shane Rountree , Frank Burkamp , Christina Bell , Lauren Proctor , Matthew Duncan Helm , Colin O'Dowd , Timothy Harrison
- Applicant: ALMAC DISCOVERY LIMITED
- Applicant Address: GB Craigavon
- Assignee: ALMAC DISCOVERY LIMITED
- Current Assignee: ALMAC DISCOVERY LIMITED
- Current Assignee Address: GB Craigavon
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque
- Priority: GB1612938 20160726
- International Application: PCT/GB2017/052178 WO 20170726
- International Announcement: WO2018/020242 WO 20180201
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; C07D417/14 ; A61P35/00 ; A61P21/00 ; A61P25/16 ; C07D491/10 ; C07D401/04
Abstract:
The present invention relates to compounds of Formula (I) that are useful as inhibitors of the activity of the ubiquitin specific protease USP19. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in therapy.
Public/Granted literature
- US20190233394A1 PHARMACEUTICAL COMPOUNDS Public/Granted day:2019-08-01
Information query
